Corporate ActionMay 20, 2026, 04:38 PM
NanoViricides Raises ~$2M in Registered Direct Offering
AI Summary
NanoViricides, Inc. completed a registered direct offering, raising approximately $2.0 million in gross proceeds. The offering included 1,333,334 units, each consisting of common stock (or pre-funded warrants) and accompanying common warrants. The net proceeds are intended for working capital, R&D, clinical trials, and strategic acquisitions.
Key Highlights
- Gross proceeds of approximately $2.0 million from the offering.
- Offering included 1,133,334 common shares at $1.50 per share.
- Pre-funded warrants for up to 200,000 shares at $1.49999 per warrant.
- Common warrants for 1,333,334 shares, exercisable at $1.75 per share.
- Placement agent D. Boral Capital LLC received a 7.0% cash fee.
- Net proceeds for working capital, R&D, clinical trials, and acquisitions.
- CEO subject to a 30-day lock-up agreement on shares.
Price Impact
More from NNVC